Atria Investments Inc Sells 400 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Atria Investments Inc reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,095 shares of the company’s stock after selling 400 shares during the quarter. Atria Investments Inc’s […]
Atria Investments Inc reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,095 shares of the company’s stock after selling 400 shares during the quarter. Atria Investments Inc’s […]
